| Similar Articles |
|---|
 |
Pharmaceutical Executive
April 10, 2014 |
Obama Policies Reshape Pharma Marketing Health reform initiatives promote transparency, challenge reimbursement, writes Jill Wechsler.   |
Pharmaceutical Executive
August 1, 2012
Debbie Warner |
Adapting to a New Era of Cancer Care Coverage and treatment decisions will be driven by value and defined differently by each stakeholder. |
Pharmaceutical Executive
September 1, 2011
Jill Wechsler |
Rebates and Reform User-fee renewal legislation sets the stage for new policies affecting reimbursement, research, and regulatory oversight. |
BusinessWeek
May 10, 2004
John Carey |
Drug Prices: A New Covenant? The states' growing negotiating clout with Big Pharma raises crucial questions |
Pharmaceutical Executive
November 1, 2006 |
Alternative Media: Time to Change the Channel Upgraded hospital television and Internet systems equal new marketing opportunities. |
Pharmaceutical Executive
February 1, 2013
Jill Wechsler |
Breakthrough Year for New Drugs More new medicines gained market approval, but marketers face resistance from payers looking to cut healthcare spending. |
